Type of Care:
Substance use treatment Mental health treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Outpatient
Pharmacotherapies:
Fluphenazine Haloperidol Loxapine Perphenazine Aripiprazole Brexpiprazole Clozapine Lurasidone Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI
Treatment Approaches:
Activity therapy Cognitive behavioral therapy Group therapy Integrated Mental and Substance Use Disorder treatment Individual psychotherapy Telemedicine/telehealth therapy Abnormal involuntary movement scale
Emergency Mental Health Services:
Crisis intervention team
Facility Operation (e.g., Private, Public):
Private non-profit organization
Special Programs/Groups Offered:
Clients with co-occurring mental and substance use disorders Persons 18 and older with serious mental illness (SMI)
Assessment/Pre-treatment:
Screening for tobacco use
Testing:
Metabolic syndrome monitoring
Education and Counseling Services:
Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy :
Smoking permitted in designated area
Age Groups Accepted:
Young Adults Adults Seniors
Facility Vaping Policy:
Vaping permitted in designated area
Ancillary Services:
Assisted Outpatient Treatment Court-ordered outpatient treatment Diet and exercise counseling Illness management and recovery Psychosocial rehabilitation services Vocational rehabilitation services Suicide prevention services